Their dual role in both diagnostics and therapy makes FAP-binding radiopharmaceuticals promising candidates in cancer treatment, contributing to high accuracy in detecting cancer cells and offering personalized treatment options [7,8,9]. This evidence concerns the gene FAP and cancer.